313.40DKK-2.25%Mkt Cap: 5.45B DKKP/E: 30.76Last update: 2026-05-13
ChemoMetec A/S engages in the development, production, and sale of analytical equipment for cell counting and analysis the United States, Canada, Europe, and internationally. The company offers its solutions in the areas…
Industry Peers
Medical Devicesloading…
Indicators:|
Key Statistics
Valuation
P/E (Trailing)30.76
P/E (Forward)24.61
PEG—
P/B8.36
P/S11.06
EV/EBITDA21.23
EV/Revenue10.51
EPS (TTM)10.19
EPS (Forward)12.73
Cash Flow & Leverage
FCF Yield2.27%
FCF Margin25.06%
Operating CF207.45M DKK
CapEx (TTM)64.73M DKK
Net Debt/EBITDA-1.10
Net Debt-269.45M DKK
Technical
SMA 50334.02 (-6.2%)
SMA 200552.70 (-43.3%)
Beta1.33
S&P 52W Chg24.23%
Avg Vol (30d)82.13K
Avg Vol (10d)103.65K
Technical Indicators
RSI (14)42.9
MACD-7.9243
MACD Signal-9.3699
MACD Hist.+1.4455
BB Upper350.22 DKK
BB Middle326.20 DKK
BB Lower302.18 DKK
BB Width14.73%
ATR (14)15.70 DKK
Vol Ratio (20d)0.73x
52W Range
235.2014% of range804.00
52W High804.00 DKK
52W Low235.20 DKK
Profitability
Gross Margin93.93%
EBITDA Margin49.51%
Profit Margin37.61%
Oper. Margin48.42%
ROE27.68%
ROA22.51%
Revenue Growth-1.00%
Earnings Growth-9.10%
Balance Sheet
Debt/Equity0.01
Current Ratio3.93
Quick Ratio3.02
Book Value/Sh37.50 DKK
Cash/Share15.78 DKK
Dividends
Fwd Div Rate7.000 DKK
Trail. Div Rate7.000 DKK
Div. Yield2.23%
5Y Avg Yield—
Payout Ratio68.83%
Ex-Div DateOct 10, 2025
Pay Date—
Ownership
Shares Out.17.40M
Float16.74M
Insiders3.73%
Institutions53.24%
Analyst Consensus
Rating1.0 (Strong Buy)
Target (Mean)546.25 DKK
Target Range450.00 DKK – 650.00 DKK
# Analysts4
Company
Market Cap5.45B DKK
Enterprise Value5.18B DKK
Revenue (TTM)493.12M DKK
Gross Profit465.51M DKK
Net Income (TTM)186.41M DKK
Revenue/Share28.33 DKK
Fiscal Year EndJun 2025
MR QuarterDec 2025
Employees172
Last Price313.40 DKK
CountryDK
SectorHealthcare
IndustryMedical Devices
ISINDK0060055861